ORPHA:59303
Neonatal ichthyosis-sclerosing cholangitis syndrome
Also known as: IHSC · Ichthyosis-hypotrichosis-sclerosing cholangitis syndrome · NISCH syndrome
Publications
28,156
Trials
0
Interventional, condition-specific
Researchers
1,181
Distinct authors in sample
Gene link
CLDN1
Definitive
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
ichthyosis-sclerosing cholangitis (NISCH syndrome) is a very rare complex ichthyosis syndrome characterized by scalp hypotrichosis, scarring alopecia, ichthyosis and sclerosing cholangitis.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0011874
- MeSH:C564365
- OMIM:607626
- UMLS:C1843355
Additional Mondo synonyms (2)
ichthyosis-hypotrichosis-sclerosing cholangitis syndrome · neonatal ichthyosis-sclerosing cholangitis syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Definitive — CLDN1
- LiteraturePresent
28,156 matched papers (21,013 in last 10 years) Source
- Phenotype characterisedPresent
40 HPO annotations (e.g. Sparse eyelashes; Jaundice; Cholestasis) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 100 for broader category sclerosing cholangitis
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (CLDN1).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
40
Associated phenotypes · MONDO:0011874
- Sparse eyelashes
- Jaundice
- Cholestasis
- Splenomegaly
- Sparse scalp hair
Showing 5 of 40 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-27
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
28,156
28,156 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
28,156 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
21,013 in the last 10 years · low confidence
Phrase hits: 243 · MeSH hits: 2
Who's working on it?
1,181
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Wang Y7 papers · 2025
‡Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai Institute for Pediatric Research, 1665 Kongjiang Road, Shanghai 200092, China.
Papers in Europe PMC - 02Zhang Y6 papers · 2022
Department of Orthopaedic Surgery, New York University Medical Center, New York, NY, 10003.
Papers in Europe PMC - 03Zhou Y6 papers · 2022
†Department of Pediatric Surgery, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University (SJTU), 1665 Kongjiang Road, Shanghai 200092, China.
Papers in Europe PMC - 04Hadj-Rabia S5 papers · 2022
Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France.
Papers in Europe PMC - 05Cai W4 papers · 2017
†Department of Pediatric Surgery, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University (SJTU), 1665 Kongjiang Road, Shanghai 200092, China.
Papers in Europe PMC - 06Hohl D4 papers · 2022
Department of Dermatology, University Hospital Center of Lausanne, Lausanne, Switzerland.
Papers in Europe PMC - 07Vahidnezhad H4 papers · 2022
Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College and Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Papers in Europe PMC - 08Wang J4 papers · 2017
†Department of Pediatric Surgery, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University (SJTU), 1665 Kongjiang Road, Shanghai 200092, China.
Papers in Europe PMC - 09Wen J4 papers · 2017
‡Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai Institute for Pediatric Research, 1665 Kongjiang Road, Shanghai 200092, China.
Papers in Europe PMC - 10Xiao Y4 papers · 2022
‡Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai Institute for Pediatric Research, 1665 Kongjiang Road, Shanghai 200092, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 100 trials are registered for sclerosing cholangitis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 9 September 2026 · last trial check 9 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
100 interventional trials matched sclerosing cholangitis, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: sclerosing cholangitis
100
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06975150·NOT YET RECRUITING·Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis (PSC)·Matched via name phrase
- NCT05295680·RECRUITING·Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
Conditions: Primary Sclerosing Cholangitis·Matched via name phrase
- NCT06286709·RECRUITING·FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
Conditions: Primary Sclerosing Cholangitis · Inflammatory Bowel Diseases·Matched via name phrase
- NCT07477782·NOT YET RECRUITING·Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation
Conditions: Primary Sclerosing Cholangitis (PSC) · Inflammatory Bowel Disease (IBD)·Matched via name phrase
- NCT05462093·NOT YET RECRUITING·Clinical Application of Annual Liver Multiscan and MRCP+ in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis·Matched via name phrase
- NCT06886360·NOT YET RECRUITING·Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis·Matched via name phrase
- NCT06455280·RECRUITING·A Study of SIPLIZUMAB in AILD and LT Patients
Conditions: Autoimmune Liver Disease · Liver Transplant Disorder · Autoimmune Hepatitis · Primary Sclerosing Cholangitis·Matched via name phrase
- NCT05835505·RECRUITING·Detoxification of the Liver In PSC (Dolphin)
Conditions: Primary Sclerosing Cholangitis·Matched via name phrase
- NCT05876182·RECRUITING·Vancomycin in Primary Sclerosing Cholangitis in Italy
Conditions: Primary Sclerosing Cholangitis · Liver and Intrahepatic Bile Duct Disorder · IBD·Matched via name phrase
- NCT05912387·RECRUITING·Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Conditions: Primary Sclerosing Cholangitis · Inflammatory Bowel Diseases·Matched via name phrase
- NCT06197308·RECRUITING·Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
Conditions: Primary Sclerosing Cholangitis·Matched via name phrase
- NCT07341282·NOT YET RECRUITING·Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
Conditions: Ulcerative Colitis (UC) · Primary Sclerosing Cholangitis (PSC)·Matched via name phrase
- NCT07387549·RECRUITING·A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis·Matched via name phrase
- NCT02137668·RECRUITING·Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis · Biliary Atresia·Matched via name phrase
- NCT07646223·NOT YET RECRUITING·Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis
Conditions: Ulcerative Colitis (UC) · Primary Sclerosing Cholangitis (PSC) · Pediatric Inflammatory Bowel Diseases·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-27
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Neonatal ichthyosis-sclerosing cholangitis syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Neonatal ichthyosis-sclerosing cholangitis syndrome" OR "Ichthyosis-hypotrichosis-sclerosing cholangitis syndrome" OR "NISCH syndrome") OR (MESH:"Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis") OR ("CLDN1" OR "CLDN1 syndrome" OR "CLDN1-related")MeSH descriptor terms unioned into the query: Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Neonatal ichthyosis-sclerosing cholangitis syndrome" OR "Ichthyosis-hypotrichosis-sclerosing cholangitis syndrome" OR "NISCH syndrome" OR "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"sclerosing cholangitis"
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: IHSC
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (28156) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-26T02:30:29.750Z
